Efficacy of Ezetimibe for the patients with Non-alcoholic fatty liver disease (NAFLD)
Not Applicable
- Conditions
- on-alcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000001071
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. past history of hypersensitivity to Ezetimibe 2. clinical sighs of severe liver injury such as acute hepatitis, acute exacerbation of chronic hepatitis, cirrhosis in Child B or C, hepatocellular carcinoma, and jaundice in combination with Statin. 3. women who are or possibly pregnant 4. past history of atherosclerotic disease(myocardial infarction , angina pectoris, cerebral stroke, and so on). 5. secondry hyperlipidemia or drug induced hyperlipidemia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method